Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$2.62
-2.4%
$1.69
$1.32
$4.98
$655.78M2.594.17 million shs2.58 million shs
Bioventus Inc. stock logo
BVS
Bioventus
$6.73
-0.5%
$7.02
$5.81
$14.38
$554.20M0.81385,652 shs17,413 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$3.20
-2.9%
$3.36
$0.88
$4.67
$168.15M1.253.56 million shs847,984 shs
SiBone stock logo
SIBN
SiBone
$15.69
+3.2%
$15.60
$11.70
$20.05
$676.18M0.83424,586 shs128,527 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
+7.39%+41.21%+68.65%+44.00%+48.21%
Bioventus Inc. stock logo
BVS
Bioventus
+1.65%+0.75%-6.24%-8.53%-41.67%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+1.86%+4.11%-26.89%+24.62%+222.55%
SiBone stock logo
SIBN
SiBone
-0.78%+6.59%-5.70%-19.01%+13.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$2.62
-2.4%
$1.69
$1.32
$4.98
$655.78M2.594.17 million shs2.58 million shs
Bioventus Inc. stock logo
BVS
Bioventus
$6.73
-0.5%
$7.02
$5.81
$14.38
$554.20M0.81385,652 shs17,413 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$3.20
-2.9%
$3.36
$0.88
$4.67
$168.15M1.253.56 million shs847,984 shs
SiBone stock logo
SIBN
SiBone
$15.69
+3.2%
$15.60
$11.70
$20.05
$676.18M0.83424,586 shs128,527 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
+7.39%+41.21%+68.65%+44.00%+48.21%
Bioventus Inc. stock logo
BVS
Bioventus
+1.65%+0.75%-6.24%-8.53%-41.67%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+1.86%+4.11%-26.89%+24.62%+222.55%
SiBone stock logo
SIBN
SiBone
-0.78%+6.59%-5.70%-19.01%+13.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.40
Hold$3.0014.72% Upside
Bioventus Inc. stock logo
BVS
Bioventus
2.75
Moderate Buy$13.75104.46% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.00
Hold$12.00275.59% Upside
SiBone stock logo
SIBN
SiBone
2.50
Moderate Buy$23.6750.84% Upside

Current Analyst Ratings Breakdown

Latest MBOT, SIBN, BFLY, and BVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
SiBone stock logo
SIBN
SiBone
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
SiBone stock logo
SIBN
SiBone
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/11/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$9.00 ➝ $12.00
8/21/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
8/11/2025
SiBone stock logo
SIBN
SiBone
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$25.00
8/5/2025
SiBone stock logo
SIBN
SiBone
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$25.00
8/4/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingPositive$2.00
(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$82.06M8.02N/AN/A$0.79 per share3.31
Bioventus Inc. stock logo
BVS
Bioventus
$564.14M0.99$0.53 per share12.58$2.80 per share2.40
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
SiBone stock logo
SIBN
SiBone
$167.18M4.05N/AN/A$3.98 per share3.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23MN/AN/A14.62N/A-7.11%15.61%4.01%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.58N/AN/AN/AN/A-76.27%-67.54%11/12/2025 (Estimated)
SiBone stock logo
SIBN
SiBone
-$30.91M-$0.56N/AN/AN/A-12.83%-14.20%-10.38%11/11/2025 (Estimated)

Latest MBOT, SIBN, BFLY, and BVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.10-$0.02-$0.10$1.00 millionN/A
8/4/2025Q2 2025
SiBone stock logo
SIBN
SiBone
-$0.19-$0.14+$0.05-$0.14$48.12 million$48.63 million
8/1/2025Q2 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
5.68
4.14
Bioventus Inc. stock logo
BVS
Bioventus
1.85
1.41
0.99
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
12.06
12.06
SiBone stock logo
SIBN
SiBone
0.21
8.38
7.00

Institutional Ownership

CompanyInstitutional Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
SiBone stock logo
SIBN
SiBone
98.11%

Insider Ownership

CompanyInsider Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
25.18%
Bioventus Inc. stock logo
BVS
Bioventus
33.00%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
SiBone stock logo
SIBN
SiBone
4.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460251.74 million188.35 millionOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20082.68 million54.46 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2052.80 million50.29 millionOptionable
SiBone stock logo
SIBN
SiBone
35043.14 million41.42 millionOptionable

Recent News About These Companies

SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 Shares
SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 Shares
SiBone (NASDAQ:SIBN) versus RxSight (NASDAQ:RXST) Critical Review
Harbor Capital Advisors Inc. Raises Stake in SiBone $SIBN
SiBone $SIBN Shares Bought by Goldman Sachs Group Inc.
SiBone (NASDAQ:SIBN) SVP Sells $52,065.56 in Stock
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$2.62 -0.07 (-2.43%)
As of 11:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Bioventus stock logo

Bioventus NYSE:BVS

$6.72 -0.04 (-0.52%)
As of 11:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$3.20 -0.10 (-2.89%)
As of 11:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

SiBone stock logo

SiBone NASDAQ:SIBN

$15.69 +0.48 (+3.16%)
As of 11:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.